中文English
ISSN 1001-5256 (Print)
ISSN 2097-3497 (Online)
CN 22-1108/R

留言板

尊敬的读者、作者、审稿人, 关于本刊的投稿、审稿、编辑和出版的任何问题, 您可以本页添加留言。我们将尽快给您答复。谢谢您的支持!

姓名
邮箱
手机号码
标题
留言内容
验证码

脂肪因子在肝硬化发病机制中的作用

魏思忱 郑国启

引用本文:
Citation:

脂肪因子在肝硬化发病机制中的作用

详细信息
  • 中图分类号: R575.2

Role of adipokine in the pathogenesis of cirrhosis of the liver

  • 摘要: 脂肪组织不再只是一个储存过剩能量的惰性组织,同时也是一个活跃的内分泌器官。脂肪组织作为旺盛的内分泌器官已得到广泛认可,其分泌的大量脂肪因子如瘦素、细胞因子等参与维持机体能量稳态和调控糖、脂代谢平衡,对全身器官系统有重要的调节功能。研究发现脂肪因子影响肝脏的炎症、纤维化和细胞死亡。本文就各种脂肪因子与肝硬化的关系作一综述。

     

  • [1] Peelman F, Waelput W, Iserentant H et al. Leptin: linking adipocyte metabolism with cardiovascular and autoimmune disease[J]. Prog Lipid Res, 2004, 43 (4) : 283-301.
    [2]Singh A, Wirtz M, Parker N, etal.Leptin-mediated chan-ges in hepatic mitochondrial metabolism, structure, and pro-tein levels[J].Proc NatlAcad SciUSA, 2009, 106 (31) :13100-13105.
    [3]Niu LW, Cao Q, Li J, et al.JAK/STAT pathway mediates leptin-induced Ⅰ collagen mRNA expression in human stel-late cells[J].Chin Pharmacool Bull, 2007, 23 (10) :1280-1285.
    [4]Marra F.Leptin and liver tissue repair:do rodent models pro-vide the answers?[J].J Hepatol, 2007, 46 (1) :12-18.
    [5]Wang J, Leclercq I, Brymora JM.Kupffer cells mediate lep-tin-induced liver fibrosis[J].Gastroenterology, 2009, 137 (2) :713-723.
    [6]Bolukbas FF, Bolukbas C, Horoz M, et al.Ghild-Pugh clas-sification dependent alterations in serum leptin levels among cirrhotic patients:a case controlled study[J].BMC Gastro-enterol, 2004, 4 (1) :23-26.
    [7] Piche T, Vandenbos F, Abakar-Mmahamat A, et al. The severity of liver fiberosis is associated high leptin levels in chronic hepatitis C[J]. Viral Hepat, 2004, 11 (11) : 91-96.
    [8]Hyogo H, Tazuma S, Arihiro K, et al.Efficacy of atorvasta-tion for the treatment of nonalcoholic steatohepatitis with dyslipideia[J].Metabolism, 2008, 57 (12) :1711-1718.
    [9]Ding X, Saxena NK, Lin S, et al.The roles of leptin and adi-ponectin:a novel paradigm in adipocytokine regulation of liver fibrosis and stellate cell biology[J].Am J Pathol, 2005, 166 (6) :1655-1669.
    [10]Caligiuri A, Bertolani C, Guerra CT, et al.Adenosine mono-phosphate-activated protein kinase modulates the activated phenotype of hepatic stellate cells[J].Hepatology, 2008, 47 (2) :668-676.
    [11]Weber TE, Kerr BJ, Spurlock ME.Regulation of hepatic per-oxisome prolierator-activated receptor alpha expression but not adiponectin by dietary protein in finishing pigs[J].J Anim Physiol Anim Nutr (Berl) , 2008, 92 (5) :569-577.
    [12] Szalowska E, Elferink MG, Hoek A, et al. Resistin is more abundant in liver than adipose tissue and is not up-regulated by lipopolysaccharide[J]. J Clin Endocrinol Metab, 2009, 94 (8) : 3051-3057.
    [13]Bertolani C, SanchoBru P, Failli P, et al.Resistin as an intra-hepatic cyctokine:overexpression during chronic injury and induction of proinflammatory actions in hepatic stellate cells[J].Am J Pathol, 2006, 169 (6) :2042-2053.
    [14]Kakizaki S, Sohara N, Yamazaki Y, et al.Elevated plasma re-sistin concentrations in patients with liver cirrhosis[J].J Gastroenterol Hepatol, 2008, 23 (1) :73-77.
    [15]Tiftikci A, Atug O, Yilmaz Y, et al.Serum levels of adipo-kines in patients with chronic HCV infection:relationship with steatosis and fibrosis[J].Arch Med Res, 2009, 40 (4) :294-298.
    [16]Fu Y, Luo L, Luo N, et al.Proinflammatory cytokine produc-tion and insulin sensitivity regulated by overexpression of re-sistin in 3T3-L1 adipocytes[J].Nutr Metab, 2006, (3) :28-37.
    [17] Bertolani C, Marra F. The role of adipokines in liver fibrosis[J]. Pathophysiology, 2008, 15 (2) : 91-101.
    [18] Jarrar MH, Baranova A, Collantes R, et al, Adipokines and cytokines in non-alcoholic fatty liver disease[J]. Aliment Pharmacol Ther, 2008, 27 (5) : 412-421.
    [19]Moschenl AR, Molnar C, Enrich B, et al.The novel adipokin Visfatin is involved in the pathogenesis of NAFLD[J].J Hep-atol, 2006, 44 (2) :S258.
    [20] Aller R, de Luis DA, Izaola O, et al. Influence of visfatin on histopathologieal changes of noalcoholic fatty liver disease[J]. Dig Dis Sci, 2009, 54 (8) : 1772-1777.
    [21] Moschen AR, Gerner R, Schroll A, et al. A key role for Pre-B cell colony-enhancing factor in experimental hepatitis[J]. Hepatology, 2011, 54 (2) :675-686.
    [22]Huang JF, Huang CF, Yu ML, et al.Serum visfatin is correla-ted with disease severity and metabolic syndrome in chronic hepatitis Cinfection[J].J Gastroenterol Hepatol, 2011, 26 (3) :530-535.
    [23]de Boer JF, Bahr MJ, Boker KH, et al.Plasma levels of PBEF/Nampt/visfatin are decreased in patients with liver cir-rhosis[J].Am J Physiol Gastrointest Liver Physiol, 2009, 296 (2) :G196-201.
    [24] Ataseven H, Bahcecioglu IH, Kuzu N, et al. The levels of ghrelin, leptin, TNF-alpha, and IL-6 in liver cirrhosis and hepatocellular carcinoma due to HBV and HDV infection[J]. Mediators Inflamm, 2006, 2006 (4) : 78380.
  • 加载中
计量
  • 文章访问数:  3413
  • HTML全文浏览量:  18
  • PDF下载量:  744
  • 被引次数: 0
出版历程
  • 出版日期:  2012-01-20
  • 分享
  • 用微信扫码二维码

    分享至好友和朋友圈

目录

    /

    返回文章
    返回